Vericel Confident in Near-Term MACI Recovery
Vericel’s MACI revenue grew 22% in 1Q20 despite mid-March disruptions from COVID-19. The company believes it has passed the market...
Vericel’s MACI revenue grew 22% in 1Q20 despite mid-March disruptions from COVID-19. The company believes it has passed the market...
The company grew in the low double digits in 1Q20 but was on pace for record procedure volumes before COVID-19...
While Stryker anticipates significant disruption to orthopedic sales in 2Q20, the company is confident the revenue-generating ability of orthopedics will...
The company declined 12.5% in 1Q20 and believes the market low point will be in the second quarter. ConMed's orthopedic...
Billions of dollars separate the top 3 orthopedic device companies from the rest of the pack. Our infographic details the...
DePuy Synthes declined 7.5% in 1Q20 due to the impact of the COVID-19 pandemic, with the worst expected to come...
Driven by additional favorable reimbursement decisions from payers and an expanding sales force, SI-BONE grew 22% in 2019....
Expansion of its sales force and portfolio drove Orthopediatrics to 26% growth in 2019 as it climbs toward the $100...
With 12 new product launches and improvement across all major growth metrics, ATEC drove 24% growth in 2019 as it...
Unable to offset the loss of Aetna coverage and the lack of a cementless knee, Conformis sales declined in the...
Login
Register for a free account
As a guest member you get access to more articles and videos every month.